Literature DB >> 9260593

Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney.

H Kirschke1, T Clausen, B Göhring, D Günther, E Heucke, F Laube, E Löwe, H Neef, H Papesch, S Peinze, G Plehn, U Rebmann, A Rinne, R Rüdrich, E Weber.   

Abstract

Renal cell carcinoma contains significantly lower concentrations of the lysosomal cysteine proteases, cathepsins B, C, H, L and S, than does normal kidney, as shown by several methods, such as activity determination, enzyme-linked immunosorbent assay, immunoblotting and immunohistochemistry. The same low levels of enzyme activity and concentration have been determined in renal cell carcinoma metastases in the lung. Our results on the decreased concentration of cysteine peptidases at the protein level would seem to conflict with earlier results on an increased concentration of the cathepsin L mRNA in renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260593     DOI: 10.1007/bf01240124

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  19 in total

1.  Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants.

Authors:  J Rozhin; D Robinson; M A Stevens; T T Lah; K V Honn; R E Ryan; B F Sloane
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

2.  Tight-binding inhibition of cathepsin S by cystatins.

Authors:  D Brömme; R Rinne; H Kirschke
Journal:  Biomed Biochim Acta       Date:  1991

3.  Proenzyme from of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody.

Authors:  M Kasai; T Shirasawa; M Kitamura; K Ishido; E Kominami; K Hirokawa
Journal:  Cell Immunol       Date:  1993-08       Impact factor: 4.868

Review 4.  Cathepsin B, Cathepsin H, and cathepsin L.

Authors:  A J Barrett; H Kirschke
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

5.  Alterations in lysosomal enzymes of the proximal tubule in gentamicin nephrotoxicity.

Authors:  C J Olbricht; M Fink; E Gutjahr
Journal:  Kidney Int       Date:  1991-04       Impact factor: 10.612

6.  Transformation-dependent secretion of a low molecular weight protein by murine fibroblasts.

Authors:  M M Gottesman
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

7.  Isolation of six cysteine proteinase inhibitors from human urine. Their physicochemical and enzyme kinetic properties and concentrations in biological fluids.

Authors:  M Abrahamson; A J Barrett; G Salvesen; A Grubb
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

8.  Cathepsin B in tumors, normal tissue and isolated cells from the human lung.

Authors:  B Werle; W Ebert; W Klein; E Spiess
Journal:  Anticancer Res       Date:  1994 May-Jun       Impact factor: 2.480

9.  Urinary excretion of cathepsin B and cystatins as parameters of tubular damage.

Authors:  L Schaefer; U Gilge; A Heidland; R M Schaefer
Journal:  Kidney Int Suppl       Date:  1994-11       Impact factor: 10.545

10.  Expression of cathepsin L in human tumors.

Authors:  S S Chauhan; L J Goldstein; M M Gottesman
Journal:  Cancer Res       Date:  1991-03-01       Impact factor: 12.701

View more
  2 in total

1.  Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease.

Authors:  Vanessa Drendel; Bianca Heckelmann; Chia-Yi Chen; Juliane Weisser; Guadalupe Espadas; Christoph Schell; Eduard Sabido; Martin Werner; Cordula A Jilg; Oliver Schilling
Journal:  Oncotarget       Date:  2017-10-19

2.  Preoperative serum cystatin-C as a potential biomarker for prognosis of renal cell carcinoma.

Authors:  Shengjie Guo; Yunfei Xue; Qiuming He; Xiaobo He; Kunbin Guo; Pei Dong; Kai Yao; Guangwei Yang; Dong Chen; Zaishang Li; Xiangdong Li; Zike Qin; Zhuowei Liu; Wenjie Cheng; Chao Guo; Meng Zhang; Hui Han; Fangjian Zhou
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.